Efficacy and tolerability of 1, 2 and 3mg/kg ropivacaine administered as a single caudal block for pain management after inguinal surgery in children aged 4-12 years with a body weight of up to 25kg: a comparative, randomized and double-blind study.
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available